• Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us

Credence Genomics Credence Genomics

Credence Genomics

  • Home
  • COVID-19
    • Infection Control Program
    • Environment Control Program
  • About Us
    • Leadership
      • Board of Directors
      • Consultants
      • Our Team
    • Partners
  • Product
    • Infectious Diseases – dxn1
      • Rapid Infection Detection (RID)
      • dxn1 BactFast
      • dxn1 FungiFast
      • dxn1 Virfast
    • Predictive – GSeek
      • GSeek Exome
      • GSeek Breast
      • GSeek ColoRectal
      • GSeek Newborn Screening
      • GSeek Carrier Screening
    • Personalized Medicine – GSeek
      • GSeek Tumor Hotspots
    • Fertility – GScan
      • Non-Invasive GScan (NIPT)
  • Services
    • Clinical Diagnosis
    • Research
  • Technology
    • NGS
    • Genetic Consultation
    • Case Studies
      • Local
      • International
      • Archives
  • FAQs
  • Testimonials
  • Contact Us
සිංහල
தமிழ்

Introducing Bactfast

BactFast by Credence Genomics is a single test that allows the identification of the entire population of known bacteria in one go, including species that are uncultivable. A diagnostic test which usually takes up to 7 days to process is now completed within 48 hours. BactFast replaces the entire cohort of conventional microbial and biochemical test methods and all of its drawbacks, generating highly transparent, accurate and more reliable data in rapid turn-around time with a minimum quantity of test sample.

BactFast for Heathcare and Industries

BactFast has already proven to be a life-saving approach in nosocomial infections in patients receiving intensive care. The test can be used to detect causative agents of infections and industrial contaminations across various sectors.

Healthcare

  • Ventilator-Associated Pneumonia (VAP)
  • Central Line Associated Bloodstream Infections (CLABSI)
  • Catheter associated Urinary Tract Infections (UTI)
  • Diabetic Ulcers
  • Mixed Infections with unknown etiology

Industry

  • Food & Beverages
  • Agricultural products
  • Dairy Products
  • Pharmaceutical products
  • Cosmetic & Personal care products
  • Water/ Wastewater Treatment
  • Soil Profile investigation
  • Aviation fuel testing

With BactFast we are now able to provide new insights to aid understanding of aspects of human microbiota and their involvement in human health, immunity, metabolism and disease. As the test eliminates the need of culturing of microorganisms in the laboratory, while identifying species that are uncultivable, it has become extremely useful in rapid identification of infections. This approach will help the physicians to identify the course of therapy before the infection worsens and to prescribe specific treatment without overdosing the patients with non-specific drugs that could adversely affect other underlying diseases, imposing life threatening situations.

Key points

  • Allows Identification of Entire Spectrum of Known Bacteria in One Go
  • Culture Independent – Ability to Identify Uncultivable Species
  • Rapid Turnaround Time of Diagnostic Tests in 48 Hours
  • Includes Advanced Analysis – Relative and Comparative Analysis
  • 99% Accuracy, Highly Sensitive

Did you know?

Our bodies harbour a total of Ten Thousand Trillion microbial cells, which exceeds the total number of our own body cells. In addition, we inhale and consume an entire load of microbes each day. That makes us walking Petri dishes with shoes! Some of these microbes can be extremely pathogenic and act as causative agents of life-threatening diseases.

Why choose BactFast?

Feature Conventional Technologies BactFast
Turnaround time 7 – 10 days 48 hours
Accuracy level ~ 80 % 99.0 %
Accuracy of test Operator-dependent; Non specific error prone results Operator-independent;Highly accurate; Entirely reliable results
Throughput Limited Increased
Sensitivity Varied High
Contamination risk Hindered by non-culturable organisms Culture independent
Organisms per test One organism per test; Important organisms can be missed Entire spectrum of known bacteria; Entire population can be tested
Types of microbes detected Limited to pathogens All known organisms; Capable of advanced analysis (relative abundance, comparative abundance)

The need for better testing methods

In the past few decades, ignorance of the microbial abundance on earth was largely due to our inability to grow most of the microorganisms in a laboratory environment. Among the cultivable types of microorganisms, some were difficult to identify due to unusual biochemical reactions. Identification of microbes using conventional microbial techniques has always been cumbersome, time consuming and less accurate. When considering accuracy, conventional methods of detecting microbial species claim a 20% rate of error in results, which is unavoidable. As of late, DNA sequencing techniques have permitted the study of whole populations of microorganisms in a given environment without the need to culture any of them in a Petri dish.

BactFast analysis types offered

Detection

BactFast is capable of identifying and profiling the complete spectrum of known organisms in a single run and it requires only 48 hours of turnaround time. Additionally, the technique unveils the phylogenetic relationships of the detected organisms, providing you with enhanced analytical data.

Relative Abundances

The test represents the fraction of each species of identified microorganisms in relation to the total microorganisms in the sample, addressing your customized research requirements. This exclusive feature was always beyond the boundaries with conventional techniques.

Comparative Analysis

Another exclusive facility provided by BactFast: comparative measurements of microbial abundances under specific environmental and therapeutic conditions. This delivers accurate aspects to determine the efficacy of medical treatments, as patient samples can be checked before and after treatment.

GSeek Hotspots

Credence FungiFast

Get in touch

12-3/2 Sunethra Devi Road,
Kohuwala, Sri Lanka.

Phone: 011 2890687 / 011 2818370
Hotline: +94 71 038 0011
Email: info@credencegenomics.com

Search...

Call me back

Please fill out this form if you would want us to call you back.

captcha

Latest News Feed

https://www.credencegenomics.com/news/apollo-india-launches-dna-based-diagnostics-with-sri-lankas-credence-genomics/

Apollo India launches DNA based diagnostics with Sri Lanka’s Credence Genomics

December 3, 2017

Chennai – The Apollo Hospitals Group, India’s largest integrated... Read More

https://www.credencegenomics.com/news/eye-live-interview-dr-vaz-santosh-gnanam-ceo-director-credence-genomics/

EYE LIVE INTERVIEW DR. VAZ SANTOSH GNANAM – CEO / DIRECTOR – CREDENCE GENOMICS

December 2, 2017

Eye Live morning TV show interviewing Dr. Vaz Santosh... Read More

https://www.credencegenomics.com/news/bmc-infectious-diseases-publishes-credence-rid-bactfast-fungifast/

BMC Infectious Diseases publishes Credence RID, Bactfast & Fungifast

December 2, 2017

Credence Genomics Ltd., Sri Lanka’s premier specialised DNA diagnostics... Read More

News Archive

© Credence Genomics 2022. BenWorldwide | Feedback

Thank you

Your inquiry has been received.

Close